Amivantamab as a salvage therapy post-EGFR-tyrosine kinase inhibitor failure in patients with mutated EGFR non-small cell lung cancer
阿米万单抗作为EGFR酪氨酸激酶抑制剂治疗失败后EGFR突变型非小细胞肺癌患者的挽救治疗
期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-24-617
Krayim, Bilal; Kian, Waleed; Spector, Maria; Granot, Inbal; Dudnik, Julia; Nissim, Michal; Kahala, Dolev; Remilah, Areen Abu; Bogot, Naama R; Kornev, Gleb; Asna, Noam; Peled, Nir; Roisman, Laila C